This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jul 17, 2026
From wearability to smartphone apps to future algorithm updates; we dive into these automated insulin delivery systems to help break down the deciding factors.
Jul 14, 2026
The new "Mind in Range" collection offers free meditations, a breathing exercise, and a narrated sleep story for the diabetes community.
Jul 6, 2026
Spain is the latest European market that now has access to Omnipod 5 and Insulet products, with more planned to come later this year.
Jun 9, 2026
Open source developers are close to bringing the Omnipod 5 and Tandem Mobi insulin pumps to open source apps later this year.
Results from two Insulet studies presented at ADA point toward an automated future that demands less from the people using it.
Jun 3, 2026
Insulet is bringing a new target glucose of 100 mg/dL to Omnipod 5 to improve time in range and upgrades to increase time in automated mode.
May 27, 2026
An estimated 7 million pods fall within the scope of this correction, in the U.S. and international markets, representing about 8.5% of 2025 global Pod production.
May 4, 2026
Insulet has enrolled its first participant in its EVOLVE trial testing an automated system designed to eliminate mealtime bolus announcements for people with type 2 diabetes.
Apr 30, 2026
The FDA has classified a Class I recall for certain Omnipod 5 lots after a tubing defect was linked to 476 serious injuries.
